Dutton Associates Announces Investment Opinion: Interleukin Genetics Rating At Strong Speculative Buy In Update Coverage By Dutton Associates

Chiropractic Economics

18 years ago

Dutton Associates updates its coverage of Interleukin Genetics (AMEX:ILI) maintaining a Strong Speculative Buy